Biophytis — Company Overview, News & Financial Data

Biophytis (EPA:ALBPS), (NASDAQ:BPTS) is a biotechnology firm focused on developing drug candidates to slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19. The company's portfolio primarily targets sarcopenia and macular degeneration, conditions that significantly affect the elderly population. Biophytis conducts its work with the aim to bring innovative therapies from bench to bedside by navigating through the complex processes of clinical development and regulatory approval. The firm's dedication to combating age-related diseases underscores its commitment to improving the quality of life for an aging global population.